Avid Bioservices, Inc. (CDMO) Financials
Stock symbol CDMO is outdated, potentially delisted? Maybe it is available on other exchange?
CDMO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| July 31, 2024 | 334.6 million | 276.0 million |
| April 30, 2024 | 336.6 million | 275.7 million |
| Jan. 31, 2024 | 455.2 million | 275.1 million |
| Oct. 31, 2023 | 454.6 million | 271.0 million |
CDMO Free Cash Flow and Stock based compensation
No data available :(
CDMO Net Income
No data available :(
CDMO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| July 31, 2024 | 36.8 million | 204.6 million | 52.1 million |
| April 30, 2024 | 38.1 million | 205.0 million | 52.8 million |
| Jan. 31, 2024 | 35.5 million | 52.2 million | 53.5 million |
| Oct. 31, 2023 | 31.4 million | 52.9 million | 54.1 million |
CDMO Shares Outstanding
CDMO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| July 31, 2024 | 1.3 million | - | 8.2 million | - |
| April 30, 2024 | 5.7 million | - | 6.8 million | 800000 |
| Jan. 31, 2024 | 4.5 million | - | 6.4 million | - |
| Oct. 31, 2023 | 7.3 million | - | 6.6 million | - |
CDMO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| July 31, 2024 | 40.2 million | 34.5 million |
| April 30, 2024 | 43.0 million | 37.5 million |
| Jan. 31, 2024 | 33.8 million | 31.4 million |
| Oct. 31, 2023 | 25.4 million | 30.1 million |
CDMO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CDMO
Price: $12.49
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 451500
Ebitda: -12.0 millionMarket Capitalization: 798.9 million